Mitsubishi UFJ Asset Management
VYGR icon

Mitsubishi UFJ Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,030
Closed -$119K – 1035
2020
Q1 		$119K Buy
13,030
+2,510
+24% +$28.8K ﹤0.01% 912
2019
Q4 		$141K Buy
10,520
+4,264
+68% +$62K ﹤0.01% 921
2019
Q3 		$108K Buy
6,256
+1,015
+19% +$21.3K ﹤0.01% 897
2019
Q2 		$143K Sell
5,241
-7,933
-60% -$182K ﹤0.01% 877
2019
Q1 		$252K Buy
13,174
+1,794
+16% +$23.4K 0.01% 771
2018
Q4 		$101K Buy
11,380
+4,559
+67% +$58.5K ﹤0.01% 850
2018
Q3 		$129K Buy
+6,821
New +$131K ﹤0.01% 822

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Mitsubishi UFJ Asset Management's VYGR Position: Q2 2020 in Review

Mitsubishi UFJ Asset Management sold out of Voyager Therapeutics (VYGR) in Q2 2020, closing a stake of 13,030 shares — an estimated $119K sold.

Mitsubishi UFJ Asset Management first reported a position in VYGR in Q3 2018 and held it in 7 quarters. The position peaked at $252K in Q1 2019. 113 funds tracked by Wall St. Rank hold VYGR as of Q2 2020.

  • Mitsubishi UFJ Asset Management reported no remaining Voyager Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 13,030 Voyager Therapeutics shares in Q2 2020, an estimated $119K.
  • Mitsubishi UFJ Asset Management first reported a position in Voyager Therapeutics in Q3 2018 and held it in 7 quarters.
  • Mitsubishi UFJ Asset Management's Voyager Therapeutics position peaked at $252K in Q1 2019.
  • 113 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2020.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.